Review on Rheumatoid Arthritis

A chronic, systemic inflammatory disease that mostly affects synovial joints, rheumatoid arthritis (RA) causes gradual joint degeneration, deformity, and disability. Systemic symptoms, autoantibody production, and chronic synovial inflammation are its defining characteristics. Its development and progression are influenced by immunological, environmental, and genetic variables, albeit the precise aetiology is yet unclear. Millions of people are impacted by the illness globally, particularly women, and it has a major negative influence on quality of life. Results have improved with early diagnosis and vigorous therapy with biologics and disease-modifying anti rheumatic medications (DMARDs). However, there are still issues with managing extraarticular problems, personalised therapy, and illness prognosis. Future improvements in illness management and perhaps remission are possible with ongoing research into immunological mechanisms and targeted medicines.

Authors

Institutions

Publication Details

Journal
International Journal for Research in Applied Science and Engineering Technology
Published
2025-05-27
DOI
https://doi.org/10.22214/ijraset.2025.71581
Primary Topic
Rheumatoid Arthritis Research and Therapies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Review on Rheumatoid Arthritis

Man Bhavan Mahajan
International Journal for Research in Applied Science and Engineering Technology
Rheumatoid Arthritis Research and Therapies
article

Review on Rheumatoid Arthritis

Man Bhavan Mahajan
article en

Abstract

A chronic, systemic inflammatory disease that mostly affects synovial joints, rheumatoid arthritis (RA) causes gradual joint degeneration, deformity, and disability. Systemic symptoms, autoantibody production, and chronic synovial inflammation are its defining characteristics. Its development and progression are influenced by immunological, environmental, and genetic variables, albeit the precise aetiology is yet unclear. Millions of people are impacted by the illness globally, particularly women, and it has a major negative influence on quality of life. Results have improved with early diagnosis and vigorous therapy with biologics and disease-modifying anti rheumatic medications (DMARDs). However, there are still issues with managing extraarticular problems, personalised therapy, and illness prognosis. Future improvements in illness management and perhaps remission are possible with ongoing research into immunological mechanisms and targeted medicines.

International Journal for Research in Applied Science and Engineering TechnologyVol. 13(5)
BAIF Development Research Foundation (IN)
Openalex Percentile: Top 82%
Rheumatoid Arthritis Research and Therapies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.